[From rare mutations to classical ones, inhibition of signaling pathways in non-small cell lung cancer].

Abstract excerpt

Lung cancer is the leading cause of cancer deaths not only in Hungary but also in the world. Within this, women's lung cancer morbidity and mortality have increased significantly in recent years. For many years, we only had a chemotherapy option to treat lung cancer. The year 2005 was a major breakthrough in the treatment of non-small cell lung cancer with the advent of a new treatment strategy, targeted...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Carcinoma, Non-Small-Cell Lung
• Share to Genes, Neoplasm
• Share to Lung Neoplasms